Vitara Biomedical, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Vitara Biomedical, Inc. - overview
Established
2019
Location
Philadelphia, PA, US
Primary Industry
Medical Devices & Equipment
About
Based in Pennsylvania, US, and founded in 2019, Vitara Biomedical, Inc. develops therapeutic medical devices for premature infants and provides physiological procedures for neonatal care for newborns to help lower mortality and comorbidities. In November 2024, Vitara Biomedical, Inc. raised USD 50 million in series B funding led by new investor Sands Capital Ventures, with participation from other new investors GV, First Spark Ventures, Khosla Ventures, and Flerie Invest.
The company is developing a therapeutic platform for premature infants that is inspired by natural physiological processes and has the potential to transform neonatal care. The organization plans to use the July 2022 funding to advance its artificial womb technology for premature babies. The organization plans to use the November 2024 funding to advance its efforts toward a first-in-human clinical study of its technology.
Current Investors
Khosla Ventures, GV, Sands Capital Alternatives
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.vitara.com
Verticals
HealthTech, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.